Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2023-11-09 Report Publication Anno…
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2023
Report Publication Announcement Classification · 1% confidence The document is a short announcement (approx. 5,000 characters) from Coloplast A/S regarding the release of their Annual Report 2022/23 and Remuneration Report 2022/23. It provides a summary of key financial highlights but explicitly directs the reader to external links to view the full reports ('Se Årsrapporten 2022/23 og Vederlagsrapporten 2022/23 i nedenstående links'). According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than the Annual Report (10-K) itself. FY 2023
2023-11-09 Danish
Coloplast A/S - Årsrapport 2022/23 & Vederlagsrapport 2022/23
Annual Report Classification · 1% confidence The document is titled 'Årsrapport' (Annual Report) for the fiscal year 2022/23. It contains comprehensive financial statements, management reports, sustainability disclosures, and auditor reports. It is clearly the full annual report of Coloplast, not an announcement or a summary. FY 2023
2023-11-09 Danish
Coloplast A/S - Årsrapport 2022/23 & Vederlagsrapport 2022/23
Remuneration Information Classification · 1% confidence The document is a 'Vederlagsrapport' (Remuneration Report) for Coloplast for the 2022/23 fiscal year. It details the compensation, shareholdings, and remuneration policies for the Board of Directors and the Executive Management. This type of report is specifically mandated by corporate governance regulations (selskabslovens § 139b) and is a standard component of executive compensation disclosure, which falls under the 'DEF 14A' category in the provided schema.
2023-11-09 Danish
Annual Report (ESEF) 2023
Annual Report (ESEF) Classification · 1% confidence FY 2023
2023-11-09 English
Remuneration Information 2023
Remuneration Information Classification · 1% confidence The document is explicitly titled "Remuneration Report" and contains detailed sections on the remuneration of the Board of Directors and Executive Management, including fee structures, share options, and compliance with Danish corporate governance recommendations. This content directly aligns with the definition of a report detailing compensation for top executives and directors. The specific category for this is 'Remuneration Information' (Code: DEF 14A), although the document title is 'Remuneration Report' and the content is highly specific to compensation disclosure, which is the core function of a DEF 14A in the US context, or similar compensation reports globally. Given the provided definitions, DEF 14A is the closest match for a detailed remuneration report, even if the document is Danish in origin and not a formal SEC filing. The document is comprehensive (54,510 chars) and is the report itself, not an announcement of one.
2023-11-09 English
Coloplast A/S - Annual Report 2022/23 & Remuneration Report 2022/23
Regulatory Filings
2023-11-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.